Request Demo
Last update 28 Jul 2026
SSGJ-705
Last update 28 Jul 2026
Overview
Basic Info
Drug Type Bispecific antibody |
Synonyms 705, SSGJ 705, SSGJ-705 + [1] |
Target |
Action antagonists, inhibitors |
Mechanism HER2 antagonists(Receptor tyrosine-protein kinase erbB-2 antagonists), PD-1 inhibitors(Programmed cell death protein 1 inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
4
Clinical Trials associated with SSGJ-705NCT07646626
A Phase II Study of SSGJ-705 Plus SSGJ-612 ± Chemotherapy in Advanced HER2-Expressing Solid Tumors
NCT07022002
A Phase II Study to Evaluate the Safety and Efficacy of SSGJ-705 Monotherapy and Combination Therapy in Patients With Advanced HER2-Expressing Solid Tumors
NCT06390774
A Phase I Clinical Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of SSGJ-705 Monotherapy in Patients with Advanced Malignant Tumors
100 Clinical Results associated with SSGJ-705
Login to view more data
100 Translational Medicine associated with SSGJ-705
Login to view more data
100 Patents (Medical) associated with SSGJ-705
Login to view more data
100 Deals associated with SSGJ-705
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Locally Advanced Malignant Solid Neoplasm | Phase 2 | China | 17 Jul 2026 | |
| BRAF V600E Mutation-Positive Differentiated Thyroid Gland Carcinoma | Phase 2 | China | 17 Jun 2026 | |
| HER2 Positive Solid Tumors | Phase 2 | China | 19 Jun 2025 | |
| Advanced cancer | Phase 1 | China | 30 May 2024 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | - | 01 Dec 2021 | |
| Metastatic breast cancer | Phase 1 | - | - | |
| Stomach Cancer | Phase 1 | - | - | |
| Solid tumor | IND Approval | China | 29 Sep 2021 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free